Updated:
Regional Cancer Care Associates
Regional Cancer Care Associates is a healthcare services based in Princeton; the Altss profile covers its classification, headquarters, registration, AUM band,...
Regional Cancer Care Associates
Our specialists treat blood disorders and cancer in NJ, CT, MA, and the Washington, D.C., area. Trust Regional Cancer Care Associates.
General information
Firm type
Healthcare Services
Location
Region
North America
Country
United States
City
Princeton
Corporate office
Princeton, NJ, United States
Additional offices
Newark · Basel · Cambridge · Parsippany
Sector focus
Frequently asked questions
What types of cancer and blood disorders does RCCA treat?
RCCA treats a broad range of cancers including breast, lung, colorectal, prostate, and hematologic malignancies such as leukemia and lymphoma. It also manages non-cancer blood disorders. Care is delivered through medical oncology, hematology, infusion therapy, and supportive services across its centers.
Where are Regional Cancer Care Associates' treatment centers located?
RCCA has treatment centers in New Jersey (Princeton, Newark, Parsippany), Connecticut, Massachusetts (Cambridge), and the Washington, D.C., area. The network operates outpatient facilities designed to bring community-based care close to patients' homes.
Does RCCA participate in clinical trials?
Yes, RCCA engages in clinical trials and offers genetic counseling as part of its services. This allows patients to access investigational therapies and precision medicine approaches without traveling to large academic centers.
What is the ownership structure of RCCA?
RCCA operates as a physician-led network of community oncology practices. Specific financial ownership details, including any single-family office or private equity backing, have not been publicly disclosed. The model emphasizes independent physician governance.
Is RCCA part of a larger healthcare system or hospital network?
No, RCCA stands apart from large hospital systems. It is structured as a community oncology network, allowing patients to receive advanced treatment and clinical research in lower-cost suburban settings rather than academic medical centers.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: